BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
-13.72%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.5B
AUM Growth
+$2.5B
Cap. Flow
+$282M
Cap. Flow %
11.27%
Top 10 Hldgs %
45.64%
Holding
89
New
6
Increased
32
Reduced
5
Closed
8
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RNAC icon
76
Cartesian Therapeutics
RNAC
$267M
$2.12M 0.08%
1,723,133
XFOR icon
77
X4 Pharmaceuticals
XFOR
$70M
$1.48M 0.06%
847,879
ABOS icon
78
Acumen Pharmaceuticals
ABOS
$84.2M
$1.13M 0.05%
289,663
JNCE
79
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$861K 0.03%
+126,797
New +$861K
NEUP
80
Neuphoria Therapeutics Inc. Common Stock
NEUP
$24.4M
$692K 0.03%
80,971
RZLT icon
81
Rezolute
RZLT
$630M
$645K 0.03%
190,815
FVAM
82
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
-500,000
Closed -$4.93M
FLACU
83
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
-500,000
Closed -$4.95M
JYAC
84
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
-300,000
Closed -$2.93M
RACB
85
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
-500,000
Closed -$4.86M
EUCRU
86
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
-500,000
Closed -$4.99M
KDNY
87
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-1,800,000
Closed -$29.4M
MIRM icon
88
Mirum Pharmaceuticals
MIRM
$3.75B
-435,936
Closed -$6.95M
AMRN
89
Amarin Corp
AMRN
$311M
-16,459,965
Closed -$55.5M